KOD Kodiak Sciences Inc
Price (delayed)
$2.67
Market cap
$140.84M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.35
Enterprise value
$36.93M
Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new
Highlights
The EPS has grown by 33% YoY and by 8% from the previous quarter
Kodiak Sciences's net income has increased by 32% YoY and by 8% QoQ
The equity has declined by 43% year-on-year and by 19% since the previous quarter
Kodiak Sciences's quick ratio has decreased by 20% from the previous quarter and by 2.6% YoY
Key stats
What are the main financial stats of KOD
Market
Valuations
Earnings
Shares outstanding
52.75M
Market cap
$140.84M
Enterprise value
$36.93M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.93
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$186.85M
Net income
-$176.21M
EBIT
-$176.21M
EBITDA
-$149.5M
Free cash flow
-$117.72M
Per share
Balance sheet
Liquidity
EPS
-$3.35
EPS diluted
-$3.35
Free cash flow per share
-$2.24
Book value per share
$2.86
Revenue per share
$0
TBVPS
$6.38
Total assets
$335.58M
Total liabilities
$185.29M
Debt
$70.35M
Equity
$150.29M
Working capital
$146.36M
Debt to equity
0.47
Current ratio
6.72
Quick ratio
6.81
Net debt/EBITDA
0.7
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-45.6%
Return on equity
-89.1%
Return on invested capital
-79.1%
Return on capital employed
-56.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOD stock price
How has the Kodiak Sciences stock price performed over time
Intraday
4.3%
1 week
-11.3%
1 month
-35.04%
1 year
-38.34%
YTD
-73.17%
QTD
-4.81%
Financial performance
How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$186.85M
Net income
-$176.21M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 33% YoY and by 8% from the previous quarter
Kodiak Sciences's net income has increased by 32% YoY and by 8% QoQ
Growth
What is Kodiak Sciences's growth rate over time
Valuation
What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
0.93
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 33% YoY and by 8% from the previous quarter
The stock's P/B is 73% below its 5-year quarterly average of 3.3 and 40% below its last 4 quarters average of 1.5
The equity has declined by 43% year-on-year and by 19% since the previous quarter
Efficiency
How efficient is Kodiak Sciences business performance
KOD's ROIC is up by 25% year-on-year and by 6% since the previous quarter
KOD's return on equity is down by 11% year-on-year and by 5% since the previous quarter
Dividends
What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOD.
Financial health
How did Kodiak Sciences financials performed over time
The total assets is 81% greater than the total liabilities
The total assets has declined by 30% year-on-year and by 10% since the previous quarter
KOD's current ratio is down by 20% since the previous quarter and by 3% year-on-year
KOD's debt is 53% lower than its equity
KOD's debt to equity has soared by 52% YoY and by 18% from the previous quarter
The equity has declined by 43% year-on-year and by 19% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.